Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Chemical Preparation Area Operations – V 2.0

Posted on By


Biosimilars: SOP for Chemical Preparation Area Operations – V 2.0


Standard Operating Procedure for Chemical Preparation Area Operations in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/125/2025
Supersedes SOP/BS/125/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for safe, accurate, and GMP-compliant preparation and handling of chemicals used in upstream biosimilar operations within the designated chemical preparation area.

2. Scope

This SOP applies to the receipt, weighing, solution preparation, labeling, and storage of raw chemicals including buffers, acids, alkalis, and media supplements in the biosimilar manufacturing facility.

3. Responsibilities

  • Production Staff: Prepare and label chemical solutions as per batch requirements.
  • Warehouse Staff: Transfer materials to chemical preparation area after approval.
  • QA: Ensure proper documentation, labeling, and area cleanliness.

4. Accountability

The Production Manager is accountable for adherence to chemical preparation protocols and for maintaining a contamination-free preparation area.

5. Procedure

5.1 Area Readiness

  1. Verify area cleaning as per SOP/BS/067/2025 and record in cleaning log.
  2. Ensure availability of:
    • Weighing balances (calibrated)
    • Stirring devices
    • Personal Protective Equipment (PPE)
    • SDS (Safety Data Sheets) for each chemical

5.2 Material Transfer and Verification

  1. Receive materials from warehouse with Approved Label.
  2. Verify:
    • Name and Grade
    • Batch No. and Expiry
    • CoA match
  3. Log material details in Annexure-1: Material Receipt Log.

5.3 Chemical Solution Preparation

  1. Weigh quantity using balance within ±0.1% accuracy.
  2. Use appropriate container based on volume and reactivity.
  3. Dissolve using RO/DI water and mix until completely clear (unless otherwise instructed).
  4. Adjust pH if required using 1N HCl/NaOH with calibrated pH meter.
  5. Label the solution with:
    • Name of Solution
    • Prepared by
    • Preparation Date
    • Expiry Date
    • Batch/Lot No.
  6. Record all details in Annexure-2: Solution Preparation Log.

5.4 Storage and Use

  1. Store solutions in labeled carboys or sterile bottles based on usage.
  2. Store under specified conditions (e.g., 2–8°C, ambient) as per chemical nature.
  3. Discard expired or unused solutions after review by QA.

5.5 Cleaning and Decontamination

  1. After each batch preparation:
    • Clean all equipment using detergent and rinse with purified water.
    • Dry and store utensils in designated area.
  2. Record cleaning in Annexure-3.

6. Abbreviations

  • SDS: Safety Data Sheet
  • DI: Deionized
  • CoA: Certificate of Analysis
  • QA: Quality Assurance

7. Documents

  1. Material Receipt Log – Annexure-1
  2. Solution Preparation Log – Annexure-2
  3. Cleaning Log for Chemical Prep Area – Annexure-3

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • WHO TRS 1019 – Annex 2
  • Internal SOP on Equipment Calibration and Cleaning

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Material Receipt Log

Date Material Name Batch No. Expiry Checked By
04/05/2025 Sodium Phosphate SP2025B 03/2027 Sunita Reddy

Annexure-2: Solution Preparation Log

Date Solution Volume pH Prepared By Expiry
04/05/2025 Phosphate Buffer 10L 7.2 Ajay Verma 06/05/2025

Annexure-3: Cleaning Log for Chemical Prep Area

Date Area/Item Cleaned Method Used Cleaned By Verified By
04/05/2025 Stirrer Detergent + DI Water Sunita Reddy QA Staff

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included pH adjustment and clarified labeling instructions GMP gap assessment
See also  Biosimilars: SOP for Monitoring and Logging of Critical Parameters - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Checking Sealing Integrity during Filling Process – V 2.0
Next Post: Aerosol: SOP for Conducting Mock Recalls for Aerosol Products – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version